X0306 4 2019-04-01 false 0001271214 Intersect ENT, Inc. XENT 0001216628 HILLEMAN JERYL L C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025 false true false false Chief Financial Officer Common Stock 2019-04-01 4 M false 30000.00 13.05 A 61884.00 D Common Stock 2019-04-01 4 S false 30000.00 32.0697 D 31884.00 D Common Stock 2019-04-02 4 M false 16491.00 18.90 A 48375.00 D Common Stock 2019-04-02 4 M false 4709.00 13.05 A 53084.00 D Common Stock 2019-04-02 4 S false 16491.00 32.3421 D 36593.00 D Common Stock 2019-04-02 4 S false 4709.00 32.3421 D 31884.00 D Stock Option (right to buy) 13.05 2019-04-01 4 M false 30000.00 0.00 D 2027-01-17 Common Stock 30000.00 35334.00 D Stock Option (right to buy) 18.90 2019-04-02 4 M false 16491.00 0.00 D 2026-01-14 Common Stock 16491.00 58509.00 D Stock Option (right to buy) 13.05 2019-04-02 4 M false 4709.00 0.00 D 2027-01-17 Common Stock 4709.00 30625.00 D Includes 24,000 Restricted Stock Units. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2019. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.78 to $32.57, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.02 to $32.78, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The vesting commencement date of the option is January 1, 2017. 12.5% of the shares subject to the option vested on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months. The vesting commencement date of the option is January 1, 2016. 1/48th of the shares subject to the option vest monthly thereafter over 48 months. /s/ Jeryl L. Hilleman 2019-04-03